Homœopathic Links
DOI: 10.1055/s-0046-1816046
Case Report

Individualized Homeopathy for Symptom Relief and Quality of Life in Allergic Rhinitis: A Comprehensive Case Series

Authors

  • Ashish Kumar Dixit

    1   Department of AYUSH, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
  • Anjan Kumar Sahoo

    2   Department of ENT, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India

Abstract

Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated global health concern affecting 10 to 40% of the population, with significant psychological and cognitive implications. This case series aimed to evaluate the usefulness of individualized homeopathic treatment (IHT) for AR. This case series included 15 consecutive patients with AR, diagnosed as per the Allergic Rhinitis and its Impact on Asthma guidelines, at homeopathy outpatient department. IHT was selected based on comprehensive symptom and constitutional evaluation, guided by materia medica and, where necessary, repertorization software. Outcomes were assessed using the Visual Analogue Scale (VAS), Total Nasal Symptom Score (TNSS), Mini-Rhino-Conjunctivitis Quality of Life Questionnaire (MRQLQ), and Outcome in Relation to Impact on Daily Life (ORIDL) scores at baseline and 4-, 8-, and 12-week follow-ups. The mean age of the participants was 27.4 ± 13.5 years, with 73.3% being male. The mean duration of AR symptoms was 4.08 ± 4.03 years. Initial symptom scores significantly improved by the final visit: VAS decreased from 7.73 ± 1.62 to 0.26 ± 0.45, TNSS from 10.46 ± 2.16 to 0.46 ± 0.64, and MRQLQ from 3.39 ± 1.17 to 0.06 ± 0.09 (p < 0.001). ORIDL scores also indicated a favorable outcome (3.86 ± 0.35, p < 0.001). The most frequently prescribed remedies were Natrum muriaticum (40%), Nux vomica (20%), Calcarea carbonica (13.3%), and Pothos (13.3%). No adverse events were reported. IHT significantly improved symptoms and quality of life in AR patients, suggesting its potential as an alternative therapy. Further randomized controlled trials are needed to validate these findings.

Authors' Contributions

A.K.D. designed the study, conducted consultations, and drafted the manuscript. A.K.D. and A.K.S. performed data analysis and contributed to manuscript revision. Both reviewed clinical data, ensured compliance with reporting guidelines, and approved the final manuscript.


Patients' Consent

The authors confirm they obtained the necessary consent forms from all patients involved. These forms permit the inclusion of clinical information in the journal publication, assuring that patient identities will remain confidential and that names and initials will not be revealed. Although efforts will be made to maintain anonymity, complete protection cannot be guaranteed.




Publication History

Article published online:
06 February 2026

© 2026. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India